カテゴリ： GlobalData, アメリカ, 企業調査

Express Scripts Holding Co (ESRX)：製薬・医療：M&Aディール及び事業提携情報

◆英語タイトル：Express Scripts Holding Co (ESRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA904C10044
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：64
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers’ compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.

Express Scripts Holding Co (ESRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Debt Offering 18
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 18
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 19
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 20
Acquisition 21
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 21
Express Scripts Holding Co – Key Competitors 23
Express Scripts Holding Co – Key Employees 24
Express Scripts Holding Co – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Strategy And Business Planning 28
Jul 18, 2018: Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis 28
Financial Announcements 29
Oct 31, 2018: Express Scripts announces 2018 third quarter results 29
Aug 01, 2018: Express Scripts announces 2018 second quarter results 31
May 02, 2018: Express Scripts Reports 2018 First Quarter Financial Results 33
Feb 27, 2018: Express Scripts Announces 2017 Fourth Quarter and Full Year Results 35
Oct 24, 2017: Express Scripts Announces 2017 Third Quarter Results 37
Jul 25, 2017: Express Scripts Announces 2017 Second Quarter Results 38
Apr 24, 2017: Express Scripts Announces 2017 First Quarter Results 39
Feb 14, 2017: Express Scripts Announces 2016 Fourth Quarter and Full Year Results 40
Corporate Communications 41
Oct 09, 2018: Express Scripts readies emergency support for impacted members in advance of Hurricane Michael 41
Sep 27, 2018: Cigna announces enterprise leadership team for combined company 42
Apr 03, 2018: Express Scripts appoints Ron Guerrier as chief information officer 43
Oct 24, 2017: Express Scripts Appoints James M. Havel Chief Financial Officer 44
Jun 27, 2017: Express Scripts Elects Kathleen M. Mazzarella to Board of Directors 45
Legal and Regulatory 46
Jun 25, 2018: Pharmacy First Files Suit Against Express Scripts 46
Jan 10, 2018: Express Scripts Accredo Earns Renewed URAC Specialty Pharmacy Accreditation 47
Government and Public Interest 48
May 11, 2018: Express Scripts Statement on Administration’s Comments on Drug Pricing 48
Aug 25, 2017: Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications 49
Product News 50
Nov 06, 2018: Express Script’ myMatrixx launches myDataSense analytics tool 50
Other Significant Developments 51
Oct 17, 2018: Express scripts offers new value-based program for migraine 51
Oct 09, 2018: Express Scripts Introduces Medicare Part D Plan Offerings for 2019 52
Sep 12, 2018: Express Scripts implements emergency procedures for affected members in advance of hurricane florence 53
May 10, 2018: Innovative Value-based SafeGuardRx Program Delivers Better Care at Lower Cost for Express Scripts’ Patients and Plan Sponsors 54
May 03, 2018: Inside Rx, a Prescription Savings Program from Express Scripts, Expands List of Discounted Brand-Name Medications 55
Apr 12, 2018: Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans 56
Feb 05, 2018: Inside Rx Provides Savings on Influenza Medications 57
Jan 11, 2018: Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients 58
Oct 02, 2017: Express Scripts Introduces New Medicare Part D Saver Plan for 2018 60
Jun 07, 2017: Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse 61
Jun 01, 2017: Express Scripts Expands SafeGuardRx Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis 62
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Avista Capital Partners to Acquire United BioSource from Express Scripts 12
Parthenon Capital Acquires Bracket Global From Express Scripts 13
Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14
Halifax Group Completes Management Buyout Of Envision Pharma 15
Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To US$112 Million 16
ABS Capital Acquires ConnectYourCare From Express Scripts 17
Express Scripts Completes Private Placement Of Senior Notes Due 2017 For US$1.5 Billion 18
Express Scripts Completes Private Placement Of Senior Notes Due 2022 For US$1 Billion 19
Express Scripts Completes Private Placement Of Senior Notes Due 2015 For US$1 Billion 20
Express Scripts Completes Acquisition Of Medco Health For US$29 Billion 21
Express Scripts Holding Co, Key Competitors 23
Express Scripts Holding Co, Key Employees 24
Express Scripts Holding Co, Subsidiaries 26

List of Figures
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Express Scripts Holding Co (ESRX)：製薬・医療：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Quanta Computer Inc (2382)：企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • bet-at-home.com AG (ACX)：企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kresta Holdings Limited (KRS)：企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TripAdvisor Inc：企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Odebrecht SA：石油・ガス：M&Aディール及び事業提携情報
    Summary Odebrecht S.A. (Odebrecht) is a diversified company. It carries out engineering and infrastructure construction services, development and operation of energy and infrastructure projects and real estate development services. The company executed various engineering and construction projects s …
  • Banco de Sabadell SA：企業の戦略・SWOT・財務情報
    Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report Summary Banco de Sabadell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Autoliv, Inc.：企業の戦略・SWOT・財務情報
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • UNeMed Corp-医療機器分野：企業M&A・提携分析
    Summary UNeMed Corp (UneMed), a subsidiary of University of Nebraska Medical Center is a healthcare service provider that offers technology transfer and commercialization services. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup form …
  • Department of Defense Education Activity：企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Fujimori Kogyo Co., Ltd. (7917)：企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Harvard Bioscience Inc (HBIO)：企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Petro Matad Ltd (MATD)：企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Ryosan Company, Ltd：企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Michael J Fox Foundation for Parkinson’s Research-製薬・医療分野：企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Pierrel Spa (PRL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Kingfisher Plc：企業の戦略・SWOT・財務情報
    Kingfisher Plc - Strategy, SWOT and Corporate Finance Report Summary Kingfisher Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Exploration and Production KazMunaiGas (KMG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Exploration and Production KazMunaiGas (KMG EP), a subsidiary of National Company KazMunaiGas, is an upstream oil and gas company. The company carries out the exploration, development, production, processing and export of hydrocarbons and acquisition of oil and gas assets in Kazakhstan. Its …
  • Telefonica UK Limited：企業の戦略的SWOT分析
    Telefonica UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The AES Corp：企業の発電所・SWOT分析2018
    The AES Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • Hosken Consolidated Investments Ltd (HCI)：企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆